Home・Elenco Azioni・Cytek Biosciences Inc

Cytek Biosciences Inc

Chiusa

SettoreSettore sanitario

4.22 1.44

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

4.09

Massimo

4.22

Metriche Chiave
By Trading Economics
Entrata	25M -19M
Vendite	-18M 44M
EPS	-0.1
Margine di Profitto	-42.746
Dipendenti	678
EBITDA	-14M -14M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+33.65% upside

Dividendi
By Acuity
Utili prossimi	4 nov 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-45M 557M
Apertura precedente	2.78
Chiusura precedente	4.22

Notizie sul Sentiment di mercato

By Acuity

50%

151 / 340 Classifica in Healthcare

Cytek Biosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 ago 2026, 19:36 UTC

Cytek Biosciences Inc is higher today, supported by broader market gains amid expectations of a Federal Reserve pause on interest rate hikes.

6 ago 2026, 20:02 UTC

News

Cytek Biosciences raises 2026 revenue guidance to $207 million-$212 million, aligning with consensus. Shares are higher despite a mixed earnings report.

5 ago 2026, 22:02 UTC

News

Cytek Biosciences shares are lower in after-market hours following a second-quarter earnings miss and revenue that fell short of expectations.

4 ago 2026, 20:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting broader market trends after a notable early peak. Overall market performance has declined since Monday.

3 ago 2026, 19:56 UTC

Cytek Biosciences Inc. shares are higher today, reflecting broader market trends as major indices gain amid easing geopolitical tensions. No specific news was identified.

31 lug 2026, 19:26 UTC

Correlated Moves

Cytek Biosciences Inc shares are lower as first-quarter results show a significant decline, reflecting broader sector pressures amid rising bond yields.

30 lug 2026, 19:18 UTC

Cytek Biosciences Inc. shares are lower today, reflecting ongoing weakness and trading significantly below the 20-day moving average amid broader market volatility.

27 lug 2026, 19:56 UTC

Cytek Biosciences Inc is trading lower today, retracing from an early peak. The asset remains near the lower end of its one-month trading range.

24 lug 2026, 17:16 UTC

Cytek Biosciences Inc. shares are lower today, declining after an early peak. The asset remains below its 20-day moving average amid broader market volatility.

23 lug 2026, 19:46 UTC

Cytek Biosciences Inc. shares are trading roughly flat, reflecting limited movement since Wednesday. Earlier, shares peaked before retracing to current levels.

21 lug 2026, 19:06 UTC

Cytek Biosciences Inc shares are lower today, continuing a three-session decline amid broader market conditions. No specific news was identified to explain the movement.

20 lug 2026, 19:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting routine fluctuations near the upper end of their one-month trading range amid a broader market decline.

Confronto tra pari

Modifica del prezzo

Cytek Biosciences Inc Previsione

Obiettivo di Prezzo

By TipRanks

33.65% in crescita

Previsioni per 12 mesi

Media 5.56 USD 33.65%

Alto 7.5 USD

Basso 4.75 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Cytek Biosciences Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a Cytek Biosciences Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

151 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.